Health Care & Life Sciences » Pharmaceuticals | Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
50.00
76.80
-
-
-
1,281.40
Cost of Goods Sold (COGS) incl. D&A
-
-
824.80
1,214.50
1,214.50
1,281.40
Gross Income
-
-
824.80
1,214.50
1,214.50
1,281.40
SG&A Expense
23,936.20
38,498.30
23,342.70
15,867.90
14,350.50
9,902.60
EBIT
24,023.90
39,071.00
-
17,082.40
15,565.00
11,184
Unusual Expense
516.80
-
-
1,061.40
36,330.10
45,298.30
Pretax Income
24,528.40
39,048.80
24,107.70
19,163.60
51,891.90
33,986.20
Consolidated Net Income
24,528.40
39,048.80
24,107.70
19,163.60
51,891.90
33,986.20
Net Income
24,008.60
38,125.40
22,404.00
19,163.60
51,891.90
33,986.20
Net Income After Extraordinaries
24,008.60
38,125.40
12,797.80
19,163.60
51,891.90
33,986.20
Net Income Available to Common
24,008.60
38,125.40
32,010.20
19,163.60
51,891.90
33,986.20
EPS (Basic)
0.63
0.76
0.62
0.36
0.79
0.46
Basic Shares Outstanding
38,294.30
50,226.60
51,992.00
53,773.10
65,297.30
73,358
EPS (Diluted)
0.63
0.76
0.62
0.36
0.79
0.46
Diluted Shares Outstanding
38,294.30
50,226.60
51,992.00
53,773.10
65,297.30
73,358
EBITDA
23,886.20
38,421.50
23,342.70
15,867.90
14,350.50
9,902.60
Non-Operating Interest Income
12.30
22.30
59.90
23.50
3.10
-
Minority Interest Expense
519.90
923.40
1,703.70
-
-
-
Equity in Affiliates (Pretax)
-
-
-
1,043.40
-
-

About Ampio Pharmaceuticals

View Profile
Address
373 Inverness Parkway
Englewood Colorado 80112
United States
Employees -
Website http://www.ampiopharma.com
Updated 07/08/2019
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO.